Exondys 5

Biotech Movers: Sarepta, Paratek, PDL BioPharma
TheStreet.com
Mon, 04/24/17 - 10:14 am
Sarepta Therapeutics
Exondys 5
Paratek
omadacycline
PDL Biopharma
patents
Merck
Keytruda
​Why not everyone is buying the market hype surrounding Sarepta’s Duchenne drug - Boston Business Journal
Bizjournals.com
Sun, 11/13/16 - 11:56 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 5
eteplirsen
Sarepta Therapeutics' Greatest Threat: Anthem?
Motley Fool
Mon, 10/17/16 - 11:41 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 5
Biomarin
Anthem